Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative

Leonardo Trasande1, Teresa M Attina, Sheela Sathyanarayana

  • 1Department of Pediatrics, New York University School of Medicine, New York, New York 10016, USA. Leonardo.trasande@nyumc.org

Insights

Phthalate exposure is linked to increased odds of childhood obesity and higher BMI z-scores specifically in non-Hispanic Black children. This race/ethnicity-specific association highlights potential disparities in environmental health impacts.

Area of Science:

  • Environmental Health
  • Pediatric Endocrinology
  • Epidemiology

Background:

  • Phthalates are chemicals with known antiandrogenic effects.
  • They may also disrupt lipid and carbohydrate metabolism.
  • Urinary phthalate concentrations and childhood obesity prevalence vary across racial/ethnic groups.

Purpose of the Study:

  • To investigate the relationship between urinary phthalate metabolites and body mass indicators.
  • To analyze data from a nationally representative sample of U.S. children and adolescents.

Main Methods:

  • Cross-sectional analysis of 2,884 children aged 6-19 from the 2003-2008 NHANES.
  • Stratified and whole-sample analyses using multivariable linear and logistic regression.
  • Examined associations between BMI z-score, overweight, obesity, and phthalate metabolite concentrations, controlling for covariates.

Main Results:

  • A significant association was found between increased low-molecular-weight (LMW) phthalate metabolites and higher odds of overweight and obesity in non-Hispanic Black children.
  • Each log unit increase in LMW metabolites correlated with a 21-22% increase in overweight/obesity odds and a 0.090-SD increase in BMI z-score in this subgroup.
  • No significant associations were identified in other racial/ethnic groups or the overall sample for LMW, HMW, or DEHP metabolites.

Conclusions:

  • A specific association exists between phthalate metabolites and childhood obesity among non-Hispanic Black children in the U.S.
  • Further research is required to confirm these findings.
  • Investigating genetic/epigenomic factors or differential exposure levels may explain observed racial/ethnic disparities.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...